The Worldwide Fertility Services Industry is Expected to Reach $39 Billion by 2027 –

DUBLIN–()–The “Fertility Services – Global Market Trajectory & Analytics” report has been added to’s offering.

Amid the COVID-19 crisis, the global market for Fertility Services estimated at US$22.7 Billion in the year 2020, is projected to reach a revised size of US$39 Billion by 2027, growing at a CAGR of 8% over the analysis period 2020-2027.

Fresh Non-Donor, one of the segments analyzed in the report, is projected to record a 8.4% CAGR and reach US$21.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Frozen Non-Donor segment is readjusted to a revised 7.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $6.1 Billion, While China is Forecast to Grow at 12.2% CAGR

The Fertility Services market in the U.S. is estimated at US$6.1 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2027 trailing a CAGR of 12.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Egg and Embryo Banking Segment to Record 7.5% CAGR

In the global Egg and Embryo Banking segment, USA, Canada, Japan, China and Europe will drive the 6.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.9 Billion in the year 2020 will reach a projected size of US$3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.4 Billion by the year 2027, while Latin America will expand at a 8.9% CAGR through the analysis period.

Select Competitors (Total 44 Featured):

  • Abbott Laboratories
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Cryos International ApS
  • Eli Lilly and Company
  • EMD Serono, Inc.
  • Ferring Pharmaceuticals, Inc.
  • INVO Bioscience
  • Irvine Scientific
  • Ivftech Aps
  • Medical Electronic Systems, LLC.
  • Merck KGaA
  • Novartis AG
  • Pantec Biosolutions AG
  • Pfizer, Inc.
  • Sanofi SA
  • VIVUS, Inc.
  • Xytex Corporation

Key Topics Covered:



  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession



For more information about this report visit

Source link